{"product_id":"healgen-r-covid-19-flu-a-b-ag-combo-rapid-test-cassette-swab","title":"Healgen® COVID-19\/Flu A\u0026B Ag Combo Rapid Test Cassette, EUA RX, 25 Tests Per Kit","description":"\u003cp\u003eCOVID-19\/Flu A\u0026amp;B Ag Combo Rapid Test Cassette (Swab)* 25 Tests Per Kit\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFor Emergency Use Authorization (EUA) only.*\u003c\/li\u003e\n\u003cli\u003eFor in vitro diagnostic use.\u003c\/li\u003e\n\u003cli\u003eFor prescription use only.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories;\u003c\/p\u003e\n\u003cp\u003eThis product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens.\u003c\/p\u003e\n\u003cp\u003eThe emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and\/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.\u003c\/p\u003e\n\u003cp\u003eAuthorized Laboratories: Laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.\u003c\/p\u003e\n\u003cp\u003eHealgen® COVID-19\/Flu A\u0026amp;B Ag Combo Rapid Test Cassette (Swab) is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 by their healthcare provider within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar.\u003c\/p\u003e\n\u003cp\u003eTesting is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. § 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.\u003c\/p\u003e\n\u003cp\u003eResults are for the in vitro detection and differentiation ofSARS-CoV-2, influenza A virus, and influenza B virus protein antigens, but do not differentiate, between SARS-CoV and SARS-CoV-2 viruses and are not intended to detect influenza C antigens.\u003c\/p\u003e\n\u003cp\u003eThese viral antigens are generally detectable in anterior nasal swab specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of the disease.\u003c\/p\u003e\n\u003cp\u003eAll negative results are presumptive and should be confirmed with a molecular assay, if necessary, for patient management. Negative results do not rule out influenza or SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control measures such as isolating from others and wearing masks. Negative results should be considered in the context of an individual’s recent exposures, history, and the presence of clinical signs and symptoms consistent with each respiratory infection.\u003c\/p\u003e\n\u003cp\u003eThe Healgen® COVID-19\/Flu A\u0026amp;B Ag Combo Rapid test Cassette (Swab) is only for in vitro diagnostic use under the Food and Drug Administration’s Emergency Use Authorization. This product has not been cleared or approved.\u003c\/p\u003e\n\u003cp\u003eKey Benefits:\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDetect 3 viruses at once (SARS-CoV-2, Flu A\u0026amp;B),\u003c\/li\u003e\n\u003cli\u003eFor symptomatic individuals within 5 days of symptom onset.\u003c\/li\u003e\n\u003cli\u003eShallow nasal swab sample collection.\u003c\/li\u003e\n\u003cli\u003eSwabbing should be performed by an adult for children aged 2 to 13.\u003c\/li\u003e\n\u003cli\u003eUser must be aged 14 + to perform self test.\u003c\/li\u003e\n\u003cli\u003eSuitable for 2+ years old.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSpecifications:\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSpecimen: Nasal Swab\u003c\/li\u003e\n\u003cli\u003eTime to results: 15 minutes\u003c\/li\u003e\n\u003cli\u003eStore the test kit between 36-86°F (2-30°C)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eProduct Documentation\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0601\/5395\/4366\/files\/Healgen-COVID-19_Flu-AB-Combo-Control-Kit-Instructions-for-Use-IFU-EUA.pdf?v=1768759985\" title=\" Healgen COVID-19\/Flu A\u0026amp;B Combo Instructions for Use (IFU) EUA\"\u003eHealgen COVID-19\/Flu A\u0026amp;B Combo Instructions for Use (IFU) EUA\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0601\/5395\/4366\/files\/Healgen-COVID-19_Flu-AB-Combo-POC-Patient-Fact-Sheet.pdf?v=1768759985\" title=\"Healgen COVID-19\/Flu A\u0026amp;B Combo POC Patient Fact Sheet\"\u003eHealgen COVID-19\/Flu A\u0026amp;B Combo POC Patient Fact Sheet\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0601\/5395\/4366\/files\/Healgen-COVID-19_Flu-AB-Combo-POC-Healthcare-Providers-Fact-Sheet-HCP.pdf?v=1768759985\" title=\"Healgen COVID-19\/Flu A\u0026amp;B Combo POC Healthcare Providers Fact Sheet (HCP)\"\u003eHealgen COVID-19\/Flu A\u0026amp;B Combo POC Healthcare Providers Fact Sheet (HCP)\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0601\/5395\/4366\/files\/Healgen-COVID-19_Flu-AB-Combo-Quick-Reference-Guide.pdf?v=1768759986\" title=\"Healgen COVID-19\/Flu A\u0026amp;B Combo Quick Reference Guide\"\u003eHealgen COVID-19\/Flu A\u0026amp;B Combo Quick Reference Guide\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0601\/5395\/4366\/files\/Healgen-COVID19_Flu-AB-Combo-Instructions-for-Use-IFU-EUA.pdf?v=1768759988\" title=\"Healgen COVID-19\/Flu A\u0026amp;B Combo Control Kit Instructions for Use (IFU) EUA\"\u003eHealgen COVID-19\/Flu A\u0026amp;B Combo Control Kit Instructions for Use (IFU) EUA\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Healgen","offers":[{"title":"Default Title","offer_id":42839026630718,"sku":"GCFC-525Sa","price":250.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0601\/5395\/4366\/files\/20240810001848_7091_d2599f49-ce53-4c05-88ae-b8b1679fe4c6.png?v=1780065367","url":"https:\/\/www.mybiotests.com\/products\/healgen-r-covid-19-flu-a-b-ag-combo-rapid-test-cassette-swab","provider":"My BIO TESTS","version":"1.0","type":"link"}